The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next

  • Posted on December 20, 2024
  • By Bing News
  • 3 Views
The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next

Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate-to-severe obstructive sleep apnea (OSA) for adults with obesity.
continue reading...

Author
Bing News

You May Also Like